Day: January 17, 2024

Cibus continues to confirm tolerance of HT1 and HT3 rice traits to commercial herbicide application rates in field trials and achievement of the Cibus Powered™ standard Following another successful season of field evaluation of HT1 and HT3 rice herbicide tolerance traits, Cibus to begin field scale demonstration in the US Mid-South in preparation for product launch Cibus canola Pod Shatter Reduction (PSR) trait continues to demonstrate a high level of pod shatter reduction in seed developer genetics and achievement of the Cibus Powered™ PSR standard Multiple canola/WOSR seed developers integrating the Cibus PSR trait into their product lines in preparation for first salesSAN DIEGO, Jan. 17, 2024 (GLOBE NEWSWIRE) — Cibus, Inc. (NASDAQ: CBUS), a leading agricultural technology company that develops and licenses plant...

Rowan Project Section Location PlanFigure 1: Rowan Project Section Location PlanSection 1: Looking WestFigure 2. Rowan Mine drill section showing assay highlights for Holes RLG-23-176c and -177 through -186[1]Section 2: Looking WestFigure 3. Rowan Mine drill section showing assay highlights for Holes RLG-23-173, -174 and -175[1]Vein 101 Long Section Looking North3 g/t Au. Assay highlights from current press release shown in red [1]”>FIGURE 5. Rowan Mine longitudinal section for Vein 102 showing 2023 intercepts > 3 g/t Au. Assay highlights from current press release shown in red [1]Vein 103 Long Section Looking North

Figure 1Plan view section of holes SB-2023-006, 2023-007 and 2023-17A drilling within the proposed Mustang Mine footprint.Figure 2Hole SB-2023-006 intersection on the BK Vein.Figure 3Hole SB-2023-007 intersection on the Alhambra Vein.Figure 4Hole SB-2023-017A intersection on the BK Vein.TORONTO, Jan. 17, 2024 (GLOBE NEWSWIRE) — Talisker Resources Ltd. (“Talisker” or the “Company”) (TSX:TSK | OTCQX:TSKFF) is pleased to announce additional high-grade drill results highlighted by 36.84 g/t Au over 1.00 metres within a broader interval of 3.71 g/t over 12.50 metres at its 100% owned flagship Bralorne Gold Project. Key Points:Talisker initiated resource conversion drilling on October 17, 2023 with 15,000 metres of planned drilling. Hole SB-2023-017A intersected 36.84 g/t Au over 1.00 metres within...

Delivery part of 9,300-vehicle binding order for a national van providerCanoo Inc. AttachmentCanoo Inc. AttachmentJustin, Texas, Jan. 17, 2024 (GLOBE NEWSWIRE) — Canoo Inc. (NASDAQ: GOEV), a leading high-tech advanced mobility company, today announced Kingbee, a national work-ready van provider, will begin using Canoo LDV 130 vehicles in its fleet. Canoo delivered vehicles to Kingbee consistent with its schedule as part of a phased ramp-up manufacturing approach in Oklahoma City. Additional customer deliveries will be scheduled through 2024. “We are proud that an increasing number of our vehicles are on the roads of America, and we are looking forward to our vehicles joining Kingbee and its impressive list of customers,” said Tony Aquila, Investor, Executive Chairman, and CEO of Canoo. “Our vehicles are engineered...

All amounts shown in this press release are in United States dollars unless otherwise indicated WINNIPEG, Manitoba, Jan. 17, 2024 (GLOBE NEWSWIRE) — (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. (“NFI” or the “Company”), a leading independent global bus and coach manufacturer and a leader in electric mass mobility solutions, provided an update on its deliveries for the 13-week period ended December 31, 2023 (“2023 Q4”), and provided an update on its orders, backlog1 and financial guidance as of the end of 2023 Q4.2 All figures related to 2023 Q4 and Fiscal 2023 included in this press release are unaudited and will be finalized prior to the release of NFI’s audited financial results. “NFI finished 2023 strong as our team delivered buses, coaches, and aftermarket parts in line with our expectations,” said Paul Soubry,...

BOCA RATON, Fla., Jan. 17, 2024 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced that James Sapirstein, Chairman and CEO of First Wave BioPharma, will present at the Sequire Investor Summit 2024, which is planned for January 23-25, 2024, at Condado Vanderbilt Hotel in San Juan, Puerto Rico. Details of the event are as follows:Event: Sequire Investor Summit 2024Date:  January 23-25, 2024Presentation January 24, 10:30 AM AST, Track 3 (Salon Azul)Location: Condado Vanderbilt Hotel in San Juan, Puerto RicoRegistration: https://puertorico.srax.com/During the conference, members of the First Wave BioPharma...

BOSTON, Jan. 17, 2024 (GLOBE NEWSWIRE) — PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced the expansion of its executive team with the appointment of Mary Beth DeLena as General Counsel and Secretary. Ms. DeLena joins PepGen with over 20 years of experience advising global life science companies in a broad range of strategic, transactional, and corporate matters with extensive experience in business development, finance, securities, corporate governance, employment and commercial law. Prior to PepGen, Mary Beth spent 15 years at Alnylam Pharmaceuticals in roles of increasing responsibility, most recently serving as Senior Vice President, Deputy...

NEW YORK, Jan. 17, 2024 (GLOBE NEWSWIRE) — LXP Industrial Trust (NYSE:LXP) (“LXP”), a real estate investment trust (REIT) focused on single-tenant warehouse and distribution real estate investments, today announced it will release its fourth quarter 2023 financial results the morning of Thursday, February 15, 2024. LXP will host its conference call and webcast that same day at 8:30 a.m., Eastern Time to discuss these results. Participants may access the call and webcast by the following: Conference Call: (888) 660-6082 or (929) 201-6604Conference ID: 1576583Webcast: https://events.q4inc.com/attendee/297946487or visit: https://ir.lxp.com/events-and-presentations/events/default.aspx to access webcast link A telephone replay of the call will be available through May 15, 2024 and via webcast for one year by accessing: Telephone: (800)...

Updates fourth quarter revenue guidance to $165 to $175 million & Non-GAAP diluted EPS between $0.40 to $0.45 cents Initial 2024 revenue outlook of $680 to $740 million & Non-GAAP diluted EPS outlook between $1.60 to $1.90 Veeco to participate at upcoming 26th Annual Needham Growth ConferencePLAINVIEW, N.Y., Jan. 17, 2024 (GLOBE NEWSWIRE) — Veeco Instruments Inc. (NASDAQ: VECO) today has updated its financial guidance for the fourth quarter of 2023 and provided an initial 2024 outlook. Veeco’s management is scheduled to meet with investors and present at the 26th Annual Needham Growth Conference later today, where they will discuss Veeco’s updated 2023 guidance and provide an initial 2024 outlook. The presentation will be broadcast live at 11:45 AM ET and can be accessed on the investor relations section of Veeco’s...